KCM
IBB icon

Kornitzer Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Kornitzer Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,125
Closed -$1.03M – 563
2026
Q1 		$1.03M Hold
6,125
– – 0.02% 387
2025
Q4 		$1.03M Hold
6,125
– – 0.02% 400
2025
Q3 		$884K Buy
+6,125
New +$836K 0.02% 415

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

Kornitzer Capital Management's IBB Position: Q2 2026 in Review

Kornitzer Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 6,125 shares — an estimated $1.03M sold.

Kornitzer Capital Management first reported a position in IBB in Q3 2025 and held it in 3 quarters. The position peaked at $1.03M in Q1 2026. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Kornitzer Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Kornitzer Capital Management sold 6,125 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.03M.
  • Kornitzer Capital Management first reported a position in iShares Biotechnology ETF in Q3 2025 and held it in 3 quarters.
  • Kornitzer Capital Management's iShares Biotechnology ETF position peaked at $1.03M in Q1 2026.
  • 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.